title: [Glomerulonephritis with IgA mesangial deposits].
abstract: IgA nephropathy is the primitive glomerulonephritis the most frequently encountered worldwide. In about one case out of three, it is responsible for the progression from progressive renal failure to end-stage renal failure. The pathophysiological mechanisms of this disease which is mediated by immune complexes remain unclear. The presentation, clinical progression and optical microscope aspect of the renal biopsy may widely vary, making any histological classification very difficult. Most therapeutic studies include the patients only on clinical criteria of severity. The only consensual management is that of patients with a nephropathy and mild glomerular lesions and a nephritic syndrome, or with an extracapillar glomerulonephritis and a rapidly progressive renal failure; corticoids are indicated in former cases while corticoids must be combined with immunosuppressive agents in the latter ones. Corticotherapy may be considered in patients with a proteinuria higher than 1g/day without renal failure. In any patient with primitive IgA nephropathy, the overall management used for chronic glomerulopathy must be initiated, including, in case of arterial hypertension or proteinuria, the renin-angiotensin system blockade.
authors.affiliation: Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. evangeline.pillebout@sls.aphp.fr
authors.forename: Evangéline
authors.initials: E
authors.lastname: Pillebout
authors.forename: Dominique
authors.initials: D
authors.lastname: Nochy
mesh_terms: D001706:Biopsy; D003663:Decision Trees; D005455:Fluorescent Antibody Technique; D005922:Glomerulonephritis, IGA / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*; D006801:Humans; D007668:Kidney / Q000473:pathology; D016030:Kidney Transplantation; D011379:Prognosis